UnitedHealth Group (UNH) fundamentals: P/E, valuation, undervalued?
UnitedHealth Group · Health Care · ref. ETF XLV · price $377.76
In short — UnitedHealth Group trades at 24.3× earnings (P/E), 16.5× forward, with a net margin of 3.1 % and revenue growth of +0 %. Read: Cheap for the growth (P/E 16 for ~62% growth (PEG 0.3)).
Is UnitedHealth Group stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$377.76+5.0% over range
Oct 14, 25low $259.02 · high $436.35Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 18 analysts
Valuation : Cheap for the growth — P/E 16 for ~62% growth (PEG 0.3)
Valuation
24.3
P/E (price/earnings)
16.5
Forward P/E
0.40
PEG
3.6
Price/book (P/B)
$339.1B
Market cap
15.55
EPS
Profitability & growth
3.1 %
Net margin
+0 %
Revenue growth
+62 %
Earnings growth
$73.3B
Total debt
UnitedHealth Group income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $324.2B | $20.1B | 6.2 % |
| 2023 | $371.6B | $22.4B | 6.0 % |
| 2024 | $400.3B | $14.4B | 3.6 % |
| 2025 | $447.6B | $12.1B | 2.7 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is UnitedHealth Group's P/E and is the stock undervalued? What's a good P/E?
UnitedHealth Group's P/E is 24.3 (forward 16.5). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is UnitedHealth Group profitable?
UnitedHealth Group has a net margin of 3.1 % (EPS 15.55). The company is profitable.
Is UNH stock expensive?
Our read: "Cheap for the growth" — P/E 16 for ~62% growth (PEG 0.3). Cross-check with growth and sector.
💬 A question about UnitedHealth Group? The JPI assistant answers using our backtest data.
Keep exploring UnitedHealth Group